LPL Financial’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.3M Buy
143,079
+32,326
+29% +$6.34M 0.01% 1296
2026
Q1
$21.7M Buy
110,753
+27,367
+33% +$5.32M 0.01% 1409
2025
Q4
$14.5M Sell
83,386
-2,024
-2% -$369K ﹤0.01% 1631
2025
Q3
$16.3M Buy
85,410
+7,160
+9% +$1.27M ﹤0.01% 1494
2025
Q2
$14.1M Buy
78,250
+14,295
+22% +$2.48M ﹤0.01% 1484
2025
Q1
$10.8M Buy
63,955
+13,789
+27% +$2.27M ﹤0.01% 1538
2024
Q4
$7.57M Sell
50,166
-2,863
-5% -$445K ﹤0.01% 1751
2024
Q3
$8.23M Buy
53,029
+2,638
+5% +$394K ﹤0.01% 1615
2024
Q2
$6.9M Buy
50,391
+2,830
+6% +$388K ﹤0.01% 1622
2024
Q1
$6.33M Buy
47,561
+450
+1% +$58.4K ﹤0.01% 1620
2023
Q4
$6.5M Sell
47,111
-2,742
-6% -$360K ﹤0.01% 1523
2023
Q3
$6.08M Sell
49,853
-399
-0.8% -$53.2K ﹤0.01% 1478
2023
Q2
$7.06M Buy
50,252
+2,103
+4% +$290K 0.01% 1372
2023
Q1
$6.81M Sell
48,149
-3,014
-6% -$431K 0.01% 1322
2022
Q4
$8M Sell
51,163
-23
-0% -$3.31K 0.01% 1164
2022
Q3
$6.28M Sell
51,186
-1,511
-3% -$199K 0.01% 1217
2022
Q2
$7.01M Buy
52,697
+2,275
+5% +$310K 0.01% 1169
2022
Q1
$6.9M Sell
50,422
-5,424
-10% -$756K 0.01% 1240
2021
Q4
$9.66M Sell
55,846
-5,801
-9% -$883K 0.01% 1039
2021
Q3
$8.96M Buy
61,647
+8,334
+16% +$1.22M 0.01% 1023
2021
Q2
$7.04M Buy
53,313
+123
+0.2% +$16.1K 0.01% 1118
2021
Q1
$6.83M Sell
53,190
-2,465
-4% -$304K 0.01% 1042
2020
Q4
$6.63M Buy
55,655
+11,671
+27% +$1.42M 0.01% 960
2020
Q3
$5.04M Sell
43,984
-1,891
-4% -$223K 0.01% 957
2020
Q2
$5.23M Buy
45,875
+24,697
+117% +$2.62M 0.01% 854
2020
Q1
$1.7M Buy
21,178
+3,994
+23% +$413K ﹤0.01% 1294
2019
Q4
$1.83M Buy
17,184
+2,625
+18% +$274K ﹤0.01% 1412
2019
Q3
$1.56M Sell
14,559
-1,599
-10% -$164K ﹤0.01% 1423
2019
Q2
$1.65M Buy
16,158
+2,509
+18% +$241K ﹤0.01% 1357
2019
Q1
$1.23M Buy
13,649
+3,671
+37% +$318K ﹤0.01% 1520
2018
Q4
$831K Sell
9,978
-1,472
-13% -$138K ﹤0.01% 1674
2018
Q3
$1.24M Buy
11,450
+1,454
+15% +$159K ﹤0.01% 1526
2018
Q2
$1.1M Sell
9,996
-1,722
-15% -$179K ﹤0.01% 1560
2018
Q1
$1.18M Buy
11,718
+6,208
+113% +$636K ﹤0.01% 1486
2017
Q4
$543K Sell
5,510
-781
-12% -$74K ﹤0.01% 2002
2017
Q3
$589K Sell
6,291
-8,303
-57% -$881K ﹤0.01% 1818
2017
Q2
$1.62M Buy
+14,594
New +$1.54M 0.01% 1057
2016
Q4
Sell
-13,218
Closed -$1.11M 2700
2016
Q3
$1.11M Sell
13,218
-1,433
-10% -$120K 0.01% 1119
2016
Q2
$1.19M Buy
14,651
+3,763
+35% +$287K 0.01% 1064
2016
Q1
$778K Buy
10,888
+482
+5% +$32.3K ﹤0.01% 1854
2015
Q4
$737K Sell
10,406
-2,453
-19% -$165K ﹤0.01% 1924
2015
Q3
$816K Sell
12,859
-2,603
-17% -$182K ﹤0.01% 1397
2015
Q2
$1.1M Buy
15,462
+126
+0.8% +$9.3K 0.01% 1297
2015
Q1
$1.16M Sell
15,336
-2,713
-15% -$194K 0.01% 1247
2014
Q4
$1.21M Buy
18,049
+289
+2% +$18.2K 0.01% 1174
2014
Q3
$1.07M Sell
17,760
-1,174
-6% -$72.3K 0.01% 1222
2014
Q2
$1.11M Buy
18,934
+405
+2% +$23.7K 0.01% 1242
2014
Q1
$1.07M Sell
18,529
-3,536
-16% -$190K 0.01% 1221
2013
Q4
$1.18M Buy
22,065
+2,700
+14% +$160K 0.01% 1131
2013
Q3
$1.14M Sell
19,365
-140
-0.7% -$8.38K 0.01% 1111
2013
Q2
$1.18M Buy
+19,505
New +$1.16M 0.01% 1017

Other funds holding DGX

LPL Financial's DGX Position: Q2 2026 in Review

LPL Financial increased its Quest Diagnostics (DGX) stake by 29% in Q2 2026, buying an estimated $6.34M and bringing the position to 143,079 shares worth $30.3M. The position accounts for 0.01% of the portfolio, ranked #1296.

LPL Financial first reported a position in DGX in Q2 2013 and has held it in 51 quarters since. 634 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • LPL Financial held 143,079 shares of Quest Diagnostics worth $30.3M as of Q2 2026.
  • LPL Financial bought 32,326 Quest Diagnostics shares in Q2 2026, an estimated $6.34M.
  • Quest Diagnostics made up 0.01% of LPL Financial's portfolio in Q2 2026, its #1296 holding.
  • LPL Financial first reported a position in Quest Diagnostics in Q2 2013 and has held it in 51 quarters since.
  • 634 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.